SPACERX LLC

Medtech · Still private

Cytisine delivered via electronic vape pen for nicotine addiction treatment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Total capital: $694K

Federal grants: $694K; 3 awards · 2023–2024; Rank in peer group#101 of 445
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 3 pending

Capital timeline

Latest events

Aug 2024Federal grantHealth and Human S · Phase I · Revolutionizing Nicotine Vaping and Electronic Nicotine Delivery Systems Addiction Treatment through Innovative E-Vape Administration of Cytisine to Enhance Patient Adherence and Treatment Completion.$320K
Jan 2024Federal grantHealth and Human S · Phase I · Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.$55K
Mar 2023Federal grantHealth and Human S · Phase I · Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.$319K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

Federal grants#101 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 3

Jun 19, 2025PendingVarenicline Related Compounds and Methods for Treating Diseases and Conditions Including Tobacco Use DisorderUSPTOApplication 19066670
PendingVarenicline Related Compounds And Methods For Treating Diseases And Conditions Including Tobacco Use DisorderUSPTOApplication PCTUS2023073315
PendingVarenicline Related Compounds And Methods For Treating Diseases And Conditions Including Tobacco Use DisorderUSPTOApplication 63403529

AidocSimilar federal contract value in Medtech · null in contracts
COGNIZANCE BIOMARKERS, LLCSimilar federal contract value in Medtech · null in contracts
AISIGHT HEALTH INCSimilar federal contract value in Medtech · null in contracts
INFRADERM, LLCSimilar federal contract value in Medtech · null in contracts
SPIKE NEURO LLCSimilar federal contract value in Medtech · null in contracts
TYBR HEALTH INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.